ABG Innovation Capital Partners III GP Ltd Long-Term Concentrated

Name: ABG Innovation Capital Partners III GP Ltd Q3 2022 13F Filing | 13F Explorer
Creator: ABG Innovation Capital Partners III GP Ltd
Published: 2022-11-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001845297 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $1.475M (100.0% shares, 0.0% debt)

Holdings (5)

CSTL CASTLE BIOSCIENCES INC 59.5%

Value $877K Shares 33,626 Est. Cost $23.24 Unrealized +20.6%

WHWK AADI BIOSCIENCES INC 25.6%

Value $377K Shares 26,666 Est. Cost $30.48 Unrealized -56.9%

— SYNLOGIC INC 13.3%

Value $196K Shares 205,906 Est. Cost $2.16 Unrealized —

— IDERA PHARMACEUTICALS INC 1.4%

Value $21,000 Shares 56,250 Est. Cost $3.66 Unrealized —

GNCAQ GENOCEA BIOSCIENCES INC 0.3%

Value $4,000 Shares 375,000 Est. Cost $2.28 Unrealized -99.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CSTL	CASTLE BIOSCIENCES INC	33,626	$877K	59.5%	$23.24	+20.6%	COM	14843C105
WHWK	AADI BIOSCIENCES INC	26,666	$377K	25.6%	$30.48	-56.9%	COM	00032Q104
—	SYNLOGIC INC	205,906	$196K	13.3%	$2.16	—	COM	87166L100
—	IDERA PHARMACEUTICALS INC	56,250	$21,000	1.4%	$3.66	—	COM PAR	45168K405
GNCAQ	GENOCEA BIOSCIENCES INC	375,000	$4,000	0.3%	$2.28	-99.5%	COM NEW	372427401